Infection with hepatitis B
Indications for the use of tenofovir disoproxil 245 mg film-coated tablets for the treatment of chronic hepatitis B in adolescents aged 12 to 18 include:
Compensated liver disease and indications of an immunological disease, such as consistently increased blood ALT levels and active viral replication, or histology indications of moderate to severe inflammation and/or fibrosis. Regarding the choice to begin therapy with pediatric patients...
Adults with the following conditions may benefit from tenofovir disoproxil 245 mg film-coated tablets for the treatment of chronic hepatitis B:
-Compensated liver disease with histological evidence of ongoing inflammation and/or fibrosis, evidence of active viral replication, and consistently increased serum alanine aminotransferase (ALT) levels
-indications of the hepatitis B virus being lamivudine-resistant
-liver disease with decompensation.
Tags:hepatitis B,tenofovir disoproxil,hepatitis virus,ALT,liver,